Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Colorectal Neoplasms

Free Subscription 11.03.2024 1 Ann Surg 12 Ann Surg Oncol 3 Anticancer Res 2 BMC Cancer 1 BMC Gastroenterol 1 Br J Cancer 4 Br J Surg 1 Cancer 1 Cancer Lett 2 Cancer Res 6 Dis Colon Rectum 1 Discov Oncol 1 Eur J Cancer 2 Eur J Surg Oncol 1 Hum Pathol 4 Int J Cancer 3 Int J Colorectal Dis 2 Int J Oncol 2 J Am Coll Surg 3 J Clin Oncol 1 J Natl Cancer Inst 6 Lancet Oncol 5 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg

1. 
   How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-risk T1 Colorectal Cancer?: Erratum.
   Ann Surg. 2024;279:e4.
   PubMed        
   
   

   
   Ann Surg Oncol

2. CHIU CC
   Letter to the Editor of Annals of Surgical Oncology Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter P
   Ann Surg Oncol. 2024;31:2405-2407.
   PubMed        
   
   
3. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
   Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
   Ann Surg Oncol. 2024;31:2547-2556.
   PubMed         Abstract available
   
   
4. CHOI JS, Kim MJ, Shin R, Park JW, et al
   Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
   Ann Surg Oncol. 2024;31:2414-2424.
   PubMed         Abstract available
   
   
5. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
   ASO Visual Abstract: Double Negativity of MRI-Detected and Pathologically Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
   Ann Surg Oncol. 2024;31:2440-2441.
   PubMed        
   
   
6. HIRST N, McBride K, Steffens D
   Psychological Interventions in Prehabilitation Randomized Controlled Trials for Patients Undergoing Cancer Surgery: Sufficient or Suboptimal?
   Ann Surg Oncol. 2024;31:2183-2186.
   PubMed        
   
   
7. BOYEV A, Newhook TE
   ASO Author Reflections: Patients with Recurrence Amenable to Local Therapy for Colorectal Liver Metastases May Experience Improved Survival.
   Ann Surg Oncol. 2024;31:2600-2601.
   PubMed        
   
   
8. CHANG WJ, Chen CB, Chang YT, Wen TC, et al
   ASO Author Reflections: Advancements in Laparoscopic Parenchyma-Sparing Liver Resection: Autologous Peritoneal Patch for Middle Hepatic Vein Reconstruction in Colorectal Liver Metastasis.
   Ann Surg Oncol. 2024;31:2598-2599.
   PubMed        
   
   
9. CHOI JS, Kim MJ, Shin R, Park JW, et al
   ASO Visual Abstract: Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumor: Who Needs a Radical Resection for the Rectal Neuroendocrine Tumor 1-2 cm in Size?
   Ann Surg Oncol. 2024;31:2439.
   PubMed        
   
   
10. WACH MM, Nunns G, Hamed A, Derby J, et al
    Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2024;31:2391-2400.
    PubMed         Abstract available
    
    
11. SAKANAKA T, Iwamoto H, Matsuda K, Mitani Y, et al
    Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal Cancer.
    Ann Surg Oncol. 2024;31:2425-2438.
    PubMed         Abstract available
    
    
12. BOYEV A, Tzeng CD, Maki H, Arvide EM, et al
    ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:2606.
    PubMed        
    
    
13. SULLIVAN KM, Whelan RL, DePeralta D, Merchea A, et al
    Reply to Letter to the Editor Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the US
    Ann Surg Oncol. 2024;31:2408-2409.
    PubMed        
    
    

    
    Anticancer Res

14. ARDJMAND D, Kubota Y, Sato M, Han Q, et al
    Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells.
    Anticancer Res. 2024;44:929-933.
    PubMed         Abstract available
    
    
15. HEGEDUS D, Szemeredi N, Gabor M, Sas J, et al
    Cyclic Amines Coupled to Indole Derivatives With Improved Efflux Pump Inhibiting Activity in Bacteria and Cancer Cells.
    Anticancer Res. 2024;44:1149-1160.
    PubMed         Abstract available
    
    
16. SILVA EF, Fernandes BN, Marinello P, Deminice R, et al
    Pre and Post-high-intensity Interval Training Delays Colon Tumor Onset in a Syngeneic Mouse Model.
    Anticancer Res. 2024;44:1209-1217.
    PubMed         Abstract available
    
    

    
    BMC Cancer

17. DUAN J, Zhu L, Shi Y, Wang W, et al
    Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
    BMC Cancer. 2024;24:302.
    PubMed         Abstract available
    
    
18. HUANG JX, Zhang X, Tang M, Zhang Q, et al
    Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study.
    BMC Cancer. 2024;24:293.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

19. AOKI H, Takasawa A, Yamamoto E, Niinuma T, et al
    Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas.
    BMC Gastroenterol. 2024;24:91.
    PubMed         Abstract available
    
    

    
    Br J Cancer

20. GOURIOU C, Lemanski C, Pommier P, Le Malicot K, et al
    Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
    Br J Cancer. 2024;130:769-776.
    PubMed         Abstract available
    
    

    
    Br J Surg

21. CUK P, Tiskus M, Moller S, Lambertsen KL, et al
    Surgical stress response in robot-assisted versus laparoscopic surgery for colon cancer (SIRIRALS): randomized clinical trial.
    Br J Surg. 2024;111:znae049.
    PubMed         Abstract available
    
    
22. GLYNNE-JONES R, Harrison M
    Colorectal cancer para-aortic lymph node metastases: surgery should not be considered.
    Br J Surg. 2024;111:znad443.
    PubMed        
    
    
23. PEACOCK O
    Colorectal cancer para-aortic lymph node metastases-surgery should be considered.
    Br J Surg. 2024;111:znad445.
    PubMed        
    
    
24. PEREA J, Garcia JL, Corchete LA, Marti M, et al
    Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers.
    Br J Surg. 2024;111:znae041.
    PubMed        
    
    

    
    Cancer

25. YANG K, Doege D, Thong MSY, Koch-Gallenkamp L, et al
    Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study.
    Cancer. 2023 Nov 23. doi: 10.1002/cncr.35133.
    PubMed         Abstract available
    
    

    
    Cancer Lett

26. LIU C, Cheng X, Han K, Hong L, et al
    A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Cancer Lett. 2024 Jan 19:216663. doi: 10.1016/j.canlet.2024.216663.
    PubMed         Abstract available
    
    

    
    Cancer Res

27. FANG L, Zhang L, Wang M, He Y, et al
    Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial-Mesenchymal Transition.
    Cancer Res. 2024;84:659-674.
    PubMed         Abstract available
    
    
28. MCCOLLUM SE, Shah YM
    Stressing Out Cancer: Chronic Stress Induces Dysbiosis and Enhances Colon Cancer Growth.
    Cancer Res. 2024;84:645-647.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

29. LISKA D
    Research Perspective on: Systematic Review of Neoadjuvant Immunotherapy for Mismatch Repair Deficient Locally Advanced Colon Cancer: An Emerging Strategy.
    Dis Colon Rectum. 2024 Mar 7. doi: 10.1097/DCR.0000000000003325.
    PubMed        
    
    
30. ADAMS ED, Salem JF, Burch MA, Fleshner PR, et al
    Blinded Intraoperative Quantitative Indocyanine Green Metrics Associate With Intestinal Margin Acceptance in Colorectal Surgery.
    Dis Colon Rectum. 2024;67:549-557.
    PubMed         Abstract available
    
    
31. FEFERMAN Y, Rosen RY, Gebran S, Yuval JB, et al
    Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management.
    Dis Colon Rectum. 2024;67:496-504.
    PubMed         Abstract available
    
    
32. MASPERO M, Lavryk O, Prien C, Bandi BJ, et al
    Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis for Recurrent Rectovaginal Fistula.
    Dis Colon Rectum. 2024;67:e244.
    PubMed        
    
    
33. STEFFENS D, Blake J, Solomon MJ, Lee P, et al
    Trajectories of Quality of Life After Pelvic Exenteration: A Latent Class Growth Analysis.
    Dis Colon Rectum. 2024;67:531-540.
    PubMed         Abstract available
    
    
34. KIM HJ, Choi GS, Park JS, Park SY, et al
    Long-term Complications of Laparoscopic or Robotic Lateral Pelvic Node Dissection After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Dis Colon Rectum. 2024;67:505-513.
    PubMed         Abstract available
    
    

    
    Discov Oncol

35. MAN Y, Xin D, Ji Y, Liu Y, et al
    Identification and validation of a novel six-gene signature based on mucinous adenocarcinoma-related gene molecular typing in colorectal cancer.
    Discov Oncol. 2024;15:63.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

36. YOSHINO T, Hooda N, Younan D, Muro K, et al
    A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness.
    Eur J Cancer. 2024;202:113975.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

37. VAN DER HULST HC, van der Bol JM, Bastiaannet E, Portielje JEA, et al
    The effect of prehabilitation on long-term survival and hospital admissions in older patients undergoing elective colorectal cancer surgery.
    Eur J Surg Oncol. 2024;50:108244.
    PubMed         Abstract available
    
    
38. TONELLO M, Baratti D, Sammartino P, Di Giorgio A, et al
    External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Eur J Surg Oncol. 2023;49:604-610.
    PubMed         Abstract available
    
    

    
    Hum Pathol

39. PIHLMANN KRISTENSEN M, Korsgaard U, Timm S, Hansen TF, et al
    The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.
    Hum Pathol. 2024 Feb 28:S0046-8177(24)00033.
    PubMed         Abstract available
    
    

    
    Int J Cancer

40. HO VKY, Deijen CL, Hemmes B, van Erning FN, et al
    Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021).
    Int J Cancer. 2024;154:1569-1578.
    PubMed         Abstract available
    
    
41. JEZIORSKI K
    Improving colon cancer screening in Poland. In search of the Holy Grail.
    Int J Cancer. 2024 Mar 4. doi: 10.1002/ijc.34909.
    PubMed        
    
    
42. HORESH N, Emile SH, Garoufalia Z, Gefen R, et al
    Trends in management and outcomes of colon cancer in the United States over 15 years: Analysis of the National Cancer Database.
    Int J Cancer. 2024 Mar 7. doi: 10.1002/ijc.34910.
    PubMed         Abstract available
    
    
43. ZNAOR A, Eser S, Bendahhou K, Shelpai W, et al
    Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study.
    Int J Cancer. 2024 Mar 8. doi: 10.1002/ijc.34895.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

44. ANDERSSON J, Angenete E, Gellerstedt M, Haglind E, et al
    Developing a multivariable prediction model of global health-related quality of life in patients treated for rectal cancer: a prospective study in five countries.
    Int J Colorectal Dis. 2024;39:35.
    PubMed         Abstract available
    
    
45. WU QR, Zhao ZZ, Fan KM, Cheng HT, et al
    Pulse pressure variation guided goal-direct fluid therapy decreases postoperative complications in elderly patients undergoing laparoscopic radical resection of colorectal cancer: a randomized controlled trial.
    Int J Colorectal Dis. 2024;39:33.
    PubMed         Abstract available
    
    
46. TATSUTA K, Sakata M, Iwaizumi M, Okamoto K, et al
    Long-term prognosis after stapled and hand-sewn ileal pouch-anal anastomoses for familial adenomatous polyposis: a multicenter retrospective study.
    Int J Colorectal Dis. 2024;39:32.
    PubMed         Abstract available
    
    

    
    Int J Oncol

47. KAKAFIKA MG, Lyta AA, Gavriilidis GI, Tsiftsoglou SA, et al
    Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K?562 and colorectal HCT?116 cancer cells.
    Int J Oncol. 2024;64:42.
    PubMed         Abstract available
    
    
48. SUN J, Chen S, Zang D, Sun H, et al
    Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review).
    Int J Oncol. 2024;64:44.
    PubMed         Abstract available
    
    

    
    J Am Coll Surg

49. MASOUD SJ, Seo JE, Singh E, Woody RL, et al
    Social Vulnerability Index and Survivorship after Colorectal Cancer Resection.
    J Am Coll Surg. 2024 Mar 5. doi: 10.1097/XCS.0000000000000961.
    PubMed         Abstract available
    
    
50. 
    Discussion of Social Vulnerability Index and Survivorship after Colorectal Cancer Resection.
    J Am Coll Surg. 2024 Mar 5. doi: 10.1097/XCS.0000000000001026.
    PubMed        
    
    

    
    J Clin Oncol

51. LORIA A, Ramsdale EE, Aquina CT, Cupertino P, et al
    From Clinical Trials to Practice: Anticipating and Overcoming Challenges in Implementing Watch-and-Wait for Rectal Cancer.
    J Clin Oncol. 2024;42:876-880.
    PubMed        
    
    
52. FOKAS E, Smith JJ, Garcia-Aguilar J, Glynne-Jones R, et al
    Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited.
    J Clin Oncol. 2024;42:872-875.
    PubMed         Abstract available
    
    
53. BATTAGLIN F, Ou FS, Qu X, Hochster HS, et al
    HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.
    J Clin Oncol. 2024 Mar 8:JCO2301507. doi: 10.1200/JCO.23.01507.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

54. BEVER AM, Hang D, Lee DH, Tabung FK, et al
    Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk.
    J Natl Cancer Inst. 2024 Mar 1:djae047. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

55. HADDAD A, Lendoire M, Paolucci I, Kang HC, et al
    Optimal imaging before local therapy of colorectal liver metastases.
    Lancet Oncol. 2024;25:e99.
    PubMed        
    
    
56. GORGEC B, Sijberden JP, Swijnenburg RJ, Fretland AA, et al
    Optimal imaging before local therapy of colorectal liver metastases - Authors' reply.
    Lancet Oncol. 2024;25:e101.
    PubMed        
    
    
57. GRANATA V, Petrillo A, Setola SV, Izzo F, et al
    Optimal imaging before local therapy of colorectal liver metastases.
    Lancet Oncol. 2024;25:e100.
    PubMed        
    
    
58. MCPHAIL S, Barclay ME, Swann R, Johnson SA, et al
    Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    Lancet Oncol. 2024;25:352-365.
    PubMed         Abstract available
    
    
59. MCPHAIL S, Barclay ME, Johnson SA, Swann R, et al
    Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    Lancet Oncol. 2024;25:338-351.
    PubMed         Abstract available
    
    
60. DE ANGELIS R, Demuru E, Baili P, Troussard X, et al
    Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study.
    Lancet Oncol. 2024;25:293-307.
    PubMed         Abstract available
    
    

    
    PLoS One

61. 
    Expression of Concern: Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
    PLoS One. 2024;19:e0300484.
    PubMed        
    
    
62. GHANIPOUR L, Jansson Palmer G, Nilsson PJ, Nordenvall C, et al
    Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol.
    PLoS One. 2024;19:e0294018.
    PubMed         Abstract available
    
    
63. KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
    Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design.
    PLoS One. 2024;19:e0297773.
    PubMed         Abstract available
    
    
64. YANG Y, Mirzaei G
    Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification.
    PLoS One. 2024;19:e0293607.
    PubMed         Abstract available
    
    
65. BOUALI A, Spissu Y, Barberis A, Fadda A, et al
    Phytochemical evaluation and exploration of some biological activities of aqueous and ethanolic extracts of two species of the genus Plantago L.
    PLoS One. 2024;19:e0298518.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

66. BONNET V, Maikranz E, Madec M, Vertti-Quintero N, et al
    Cancer-on-a-chip model shows that the adenomatous polyposis coli mutation impairs T cell engagement and killing of cancer spheroids.
    Proc Natl Acad Sci U S A. 2024;121:e2316500121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.